Cassandra Berry  from Murdoch University in Perth Australia.
Share

Contact me

Phone

+619 9360 2267

Email

c.berry@murdoch.edu.au

Fellow researchers

    Latest news

    • Research
    • School

    Professor Cassandra Berry
    BSc (Hons) (UWA), PhD (UWA), SFHEA

    Professor - Immunology

    About me

    Before joining Murdoch University as an academic in 1999, I held senior research positions at The University of Western Australia (9 years) and the National Institutes of Allergy and Infectious Diseases (3 years) at NIH, Maryland, U.S.A.
    I have a Bachelor of Science degree (Double Major in Microbiology and Biochemistry) with Honours (Microbiology) and PhD in Microbiology from The University of Western Australia.  I have over 70 publications in areas of infectious disease pathogenesis, vaccines, therapeutics and education with internationally filed patents. I have been awarded grants and scholarships from the National Health and Medical Research Council, the Australian Government Department of Industry, Innovation and Science, the McCusker Charitable Foundation, the International Fogarty Fellowship, and several Medical Research Fellowships.
    In 2021, I was awarded Senior Fellowship Higher Education Academy. I won the Vice Chancellor’s Award for Excellence in Learning and Teaching in 2020 and the VC’s Citation for Excellence in Enhancing Learning in 2018. I was a finalist for VC’s Excellence in Research Supervision Award 2003, Runner-Up for WA Inventor of the Year 2007 and twice a finalist for Telstra Business Women’s Awards (2003 and 2020).
    My teaching is strongly research-informed. I have supervised 33 PhD and Honours research students. I served the Fulbright Selection Committee WA, Australian-American Commission, the International Society for Interferons and Cytokine Research, and the Australasian Society for Immunology. I advised government Health Ministers as elected Director of the Australian Society for Medical Research to advocate the value of medical research.
    I am privileged to teach 1,000 undergraduate students every year in immunology, microbiology and cell biology at Murdoch. My recent education paper describing A technique for inspiring scientific inquiry using a creative scenario. Am. Biol. Teacher 79: 671-677 (Berry 2017) enables other teachers with my research skills. As an expert in animal models and viral immunology, I have an international reputation for my work and have trained and supervised postgraduates and postdoctoral scientists in my professional roles including as invited Keynote Speaker at the Uniklinikum Essen Fellowship, Immunomodulation, Emden, Germany and as Visiting Professor, Monash Institute of Medical Research, Monash University, Victoria, Australia.

    Teaching area

    I have taught undergraduate students from 1st to 4th year level in my sub-disciplines immunology, microbiology and cell biology and designed curriculum across numerous programmes, including medicineveterinary, biomedical, chiropractic, animal, and clinical laboratory sciences. I have also supervised 33 PhD and Honours research students. Most of my units have large class sizes of approximately 100-300 students.
    • BIO152 Cell Biology
    • BMS212 Medical Microbiology
    • BMS322 Clinical Immunology
    • BSC200 Research in Physical and Life Sciences
    • BMS203 Human and Comparative Microbiology
    • VET341 Veterinary Microbiology
    • ANS351 Animal Microbiology
    • BMS265 Medical Immunology & Molecular Genetics
    • VET347 Veterinary Immunology & Molecular Genetics
    • VET431 Systemic Pathology & Medicine
    • CHI305 Immunology, Genetics & Microbiology (onshore and Japan)
    • BIO252 Immunology, Vaccines and Cell Culture
    • BMS101 Introduction to the Human Body
    • BMS315 Advances in Medical Science
    • NDM100 Medicine Notre Dame University Initiative

    Research areas

    I have led research groups in the areas of viral pathogenesis, vaccine design, innate immune responses, immunotherapeutics and treatments for autoimmune diseases. I have trained postdoctoral scientists in research and presented research findings at scientific conferences. My recent education paper is on innovative research-informed approaches for teaching research skills.

    Berry, CM. (2017). A technique for inspiring scientific inquiry using a creative scenario. Am. Biol. Teacher, 79: 671-677. 

    Current projects

    2019  S Rai, CM Berry et al,Trial for a 3D VR platform to support teaching, College Teaching and Learning Innovation Grant Murdoch University $3,000.
    2018 CM Berry et al, Building a virtual world for inside a cell: Design and development of an immersive Virtual Reality serious game for learning cell biology, Vice Chancellor’s Small Steps of Innovation $5,000.
    2017-2018 CM Berry, A Woods-McConney, Demystifying STEM career paths to girls, parents and teachers, Department of Industry, Innovation and Science, Federal Government Australia $58,300.  
    2011-2013 CM Berry, Support for Early Career Academics in the Integrated Health Research Institute Murdoch University, McCusker Charitable Foundation $900,000.

    Awards and grants

    Awards
    2020 Vice Chancellor’s Excellence in Learning and Teaching Award, Murdoch University
    2020 Top 7 Telstra Business Women’s Awards, Public and Academia sector WA
    2019  College Learning & Teaching Innovation Award, Science, Health, Engineering, Education
    2018  Vice Chancellor’s Citations in Excellence for Enhancing Learning, Murdoch University
    2018  Vice Chancellor’s Small Steps of Innovation Award, Murdoch University
    2016  School Learning and Teaching Award-Innovation, Murdoch University
    2007  Nominated Vice Chancellor’s Excellence in Teaching Award, Murdoch University
    2007  Runner up Premier’s Inventor of the Year Award, Development category WA
    2007  Nominated Premier’s Science Award, Western Australian Scientist of the Year
    2007  Nominated Vice Chancellor’s Excellence in Teaching Awards, Murdoch University
    2006  International Travel Award, Uniklinikum Essen, Fellowship, Emden Germany
    2006  International Travel Award, International Society for Interferon Cytokine Research Austria
    2003  Finalist Vice Chancellor’s Excellence in Supervision Award, Murdoch University
    2003  Finalist Telstra Business Women’s Award
    2003  Nominated Commonwealth Health Minister’s Award of Excellence
    2002  International Travel Award, International Society for Interferon Cytokine Research Italy
    1998  International Travel Award, International Society for Interferon Cytokine Research Israel
    1994  Athelston Amy Saw Medical Research Fellowship, The University of Western Australia
    1991  International Fogarty Fellowship, Visiting Associate, National Institutes of Health, US
    1989  WA and MG Saw Medical Research Fellowship, The University of Western Australia
    1984 Commonwealth Postgraduate Research Scholarship, Australia
    1983 Winner Glaxo Essay Prize, Australian Society of Microbiology
    Grants  
    Over AUS$4.5 million procured in research income, including:
    2017 Pork CRC, Principal Investigator, Protection from Escherichia coli-associated diseases after weaning in pigs using xenogeneic polyclonal antibodies specific for Escherichia coli fimbriae, (AUS$66,000).
    2011  Australian Research Council, Discovery grant, Associate Investigator with N Mangan, The role of a novel protein, interferon epsilon, in reproductive tract immunity, (AUS$799,855)
    2011  National Health and Medical Research Council, Project grant, Associate Investigator with N Mangan and P Hertzog, The role of a novel cytokine of the innate immune response in infection, (AUS$322,524)
    2007  Commercial Ready Grants, COMET, Chief Investigator A with T Ellis and S Fenwick, Avian influenza marker vaccines for poultry, (AUS$214,000)
    2006  Stone Ridge Ventures, CI with T Ellis and S Fenwick, Exogenous markers for avian influenza vaccination, (AUS$500,000)
    2000  National Health and Medical Research Council, Project grant, Sole Chief Investigator, Cell-mediated immune responses in cytomegalovirus-induced myocarditis, (AUS$234,079)
    1999  National Health and Medical Research Council, Project grant, Chief Investigator A with M Beilharz, Therapeutic antiviral efficacies of type I interferon subtypes: delivery and mechanisms of action, (AUS$351,189)
    1996  National Health and Medical Research Council, Project grant, Chief Investigator A with GR Shellam, Evaluation of molecular mimicry in cytomegalovirus induced myocarditis, (AUS$117,212)
    1996  National Health and Medical Research Council, Project grant, Chief Investigator A with M Beilharz,  In vivo antitumour and antiviral actions of type I interferons: role of individual subtypes,  (AUS$238,392)
    1994  National Health and Medical Research Council, Project grant, Chief Investigator A with MJ Garlepp, An analysis of the role of histidyl-tRNA synthetase as a target autoantigen in myositis, (AUS$258,266)
    1991  Fogarty Visiting Associate, National Institutes of Health, Recipient, Development of live attenuated influenza virus vaccines, (US$250,000)
    1989  National Heart Foundation, Grant-in-Aid, Chief Investigator A with WD Reed, Autoimmune mechanisms mediating cytomegalovirus-induced myocarditis, (AUS$70,320)

    Media and Events

    Recent interviews on COVID-19:

    • Arirang News TV Korea https://youtu.be/UN1Ck7ARzo4
    • CNN International https://www.cnn.com/2021/05/14/africa/seychelles-covid-vaccination-infection-intl-hnk-dst/index.html
    • ABC TV The Vaccine 18/06/21
    • Stuff New Zealand https://www.stuff.co.nz/world/australia/126071729/covid19-in-australia-415-new-cases-as-diabolical-delta-strain-continues-to-spread-in-nsw
    • Radio 3AW https://www.3aw.com.au/viral-immunologist-says-its-time-to-revisit-length-of-covid-19-quarantine/
    • Radio 6PR 21/06/21
    • The Mandarin https://www.themandarin.com.au/160506-supply-issues-with-covid-19-shot-sit-on-federal-governments-shoulders-expert-says/
    • ABC News https://www.abc.net.au/news/health/2021-06-19/australia-call-to-lengthen-covid-quarantine-period/100018300
    • The Conversation https://theconversation.com/novavax-is-absent-from-australias-2021-vaccination-schedule-but-it-could-be-a-useful-booster-later-on-163014
    • The Sydney Morning Herald https://www.smh.com.au/national/best-of-both-worlds-should-we-mix-or-match-vaccines-20210707-p587nb.html
    • Canberra Times Explainer https://www.canberratimes.com.au/story/7379946/why-you-shouldnt-wait-for-moderna-or-pfizer-vaccines/
    • The Australian hotel security jab have singular point of reference
    • The Conversation https://theconversation.com/do-i-still-need-to-get-a-covid-vaccine-if-ive-had-coronavirus-157599
    • The Guardian https://www.theguardian.com/world/2021/jul/07/delta-mutations-mean-young-people-less-protected-against-covid-experts-warn
    • News.com radio NZ  https://www.news.com.au/national/why-qld-nsw-avoided-outbreak-from-melbourne-couple-experts/news-story/01a69fceb71395f818116377ccfc8ef5
    • The Sydney Morning Herald https://www.smh.com.au/world/asia/some-nations-relying-on-china-s-vaccines-are-battling-outbreaks-so-do-the-vaccines-work-20210706-p5878h.html
    • The Australian Patient transport the “weak link” in NSW
    • Australian Associated Press https://www.aap.com.au/covid-19-vaccine-microchip-and-magnet-claims-dont-stick/
    • Sky News Australia https://www.skynews.com.au/australia-news/coronavirus/covid19-young-people-more-vulnerable-to-delta-mutations-than-other-variants/news-story/fd9cb8168fb59f9d0ff3a4d8b4768eb8
    • ABC News https://www.abc.net.au/news/health/2021-02-24/covid-19-pfizer-vaccine-higher-dose-what-does-science-tell-us/13186640
    • ABC News https://www.abc.net.au/news/health/2021-06-11/australians-need-to-be-vaccinated-to-stop-covid-restrictions/100195208
    • The Guardian https://www.theguardian.com/australia-news/2021/jun/10/nsw-school-founder-invites-parents-to-immunity-webinar-so-they-can-choose-not-to-take-covid-vaccine
    • The Guardian https://www.theguardian.com/world/2021/jun/19/there-are-viruses-just-waiting-in-the-wings-how-do-we-stop-the-next-pandemic
    • WION https://www.wionews.com/world/young-people-more-vulnerable-to-delta-mutations-of-covid-experts-warn-396586
    • Pedestrian TV https://www.pedestrian.tv/news/medical-experts-dr-karl-encourage-astrazeneca/
    • Daily Mail UK https://www.dailymail.co.uk/news/article-9680695/Australians-endure-snap-Covid-lockdowns-vaccination-rates-rise.html
    • The Australian https://www.theaustralian.com.au/subscribe/news/1/?sourceCode=TAWEB_WRE170_a_GGL&dest=https%3A%2F%2Fwww.theaustralian.com.au%2Fnation%2Fpolitics%2Fcoronavirus-australia-live-news-race-on-to-find-missing-link-in-nsw-mystery-case%2Fnews-story%2F3e48c8e21ad7e1393f988e705fc24386&memtype=anonymous&mode=premium
    • NZ Herald https://www.nzherald.co.nz/world/covid-19-coronavirus-us-army-scientists-warn-that-deadlier-pandemics-are-coming/5UQACBIWS3OPQRJZEBS6IPVAQI/
    • Health Feedback https://healthfeedback.org/claimreview/vaccines-are-a-safer-alternative-for-acquiring-immunity-compared-to-natural-infection-and-covid-19-survivors-benefit-from-getting-vaccinated-contrary-to-claims-by-peter-mccullough/
    • The Australian https://www.theaustralian.com.au/subscribe/news/1/?sourceCode=TAWEB_WRE170_a_GGL&dest=https%3A%2F%2Fwww.theaustralian.com.au%2Fnation%2Fpolitics%2Fcoronavirus-australia-live-news-victorian-premier-daniel-andrews-reveals-return-to-work-plan%2Fnews-story%2F4aadd41cd893af4b8f2b5e575669c534&memtype=anonymous&mode=premium
    • Body & Soul https://www.bodyandsoul.com.au/health/health-advice/15-ways-to-boost-your-immunity-that-you-havent-heard-before/news-story/0623dd737f3263fcdcfecddf87351d93
    • Health Feedback https://healthfeedback.org/claimreview/faucis-emails-dont-support-viral-claims-on-masks-hydroxychloroquine-and-virus-engineering/
    • Health Feedback https://healthfeedback.org/claimreview/covid-19-vaccines-can-enhance-protective-immunity-in-previously-infected-people/
    • The Australian https://www.theaustralian.com.au/subscribe/news/1/?sourceCode=TAWEB_WRE170_a_GGL&dest=https%3A%2F%2Fwww.theaustralian.com.au%2Fnation%2Fcoronavirus-australia-live-news-vaccination-key-to-singapore-travel-bubble%2Fnews-story%2F32b029fa503459ea5f50207b439262c2&memtype=anonymous&mode=premium
    • Imprint https://www.murdoch.edu.au/news/articles/ending-epidemics-during-the-pandemic
    • NewsHub radio NZ  https://www.newshub.co.nz/home/new-zealand/2021/05/trans-tasman-bubble-thousands-of-new-zealanders-being-chased-by-health-authorities-after-nsw-covid-19-case-closes-border.html
    • Hospital & Healthcare https://www.hospitalhealth.com.au/content/clinical-services/article/australia-s-covid-19-vaccine-rollout-commences-498850240
    • News.com https://www.news.com.au/world/coronavirus/global/covid19-vaccine-virus-outbreak-hits-seychelles-despite-most-of-the-population-being-vaccinated/news-story/84a90b6a9ac0839457fe621ea41ffa51
    • Our Generation https://en.calameo.com/read/0003734952396abcf7910
    • The West Australian Opinion Piece: Maintain the defences, the COVID fight is far from over 20/04/21
    • KalMiner Complacency a danger to letting virus spread 21/04/21
    Invited Key speaker:
    • Living Library Series, Women only event, Murdoch University, 2019
    • Women in STEM Education Showcase Day, Speaker & Panellist, Murdoch University, 9th Nov 2018
    • Women in STEM Education Showcase Day, Speaker & MC, Murdoch University, 20th July 2018
    • Women in STEM Education Showcase Day, Speaker & MC, Murdoch University, 28th March 2018
    • Women in STEM Education Showcase Day, Speaker & Panellist, Murdoch University, 10th Nov 2017
    • “Virus wars- fighting the invisible enemy” Public Lecture, Murdoch University, 12th June 2017
    • Entrepreneur Workshop Series, Start Something Program, Murdoch University 2017
    • “Novel interferon-lambda therapy for cytomegalovirus myocarditis-the heart of the matter” The Advanced Heart Failure and Cardiac Transplant Service, Royal Perth Hospital, Perth, 7th July 2011
    •  “Role of the novel cytokine IFN-epsilon in the innate immune response to infection” School of Pathology and Laboratory Medicine, UWA, Royal Perth Hospital Unit, Perth, 24th June 2011
    • “Avian influenza- a need to flock together” Monash Institute of Medical Research, Melbourne, February 2009
    • “Influenza vaccines and interferons” University of Queensland, Brisbane, January 2009
    • Avian influenza- a need to flock together” School of Medicine, Department of Microbiology, University of Otago, Dunedin, NZ, July 2008
    • Fellowship Course (Graduiertenkolleg 1045), Emden, Germany 2006
    • “Interferons- from immunotherapy to vaccines for viral diseases” Johannes Gutenberg University, Mainz, Germany, 23rd August 1998
    •  Walter and Eliza Hall Institute, Melbourne, 1998
    • Johns Hopkins University, Baltimore, USA, 1996
    • Duke University, Durham, USA, 1993
    • National Institutes of Health, Bethesda, USA, 1992

    Public presentations

    • TV: Inventor of the Year Awards (Channel 7 Innovation Special), Animal Hospital – Channel 9, Foxtel
    • University newsletter articles: Synergy, Veterinary Trust Gazette and On Campus
    • Newspaper: Health&Medicine Liftout-The West Australian, Fremantle Herald, Melville Times
    • Local Science Hero for National Science Week: to inspire young people about science (online)
    • Radio – ABC interviews by Stan Thompson, SA and Liam Bartlett, WA, Radio Australia Vic.
    • Priority Network Television: Your Say – encouraging women to have a career in biomedical science
    • Speaker: Rotary Club Rockingham – vaccination for heart disease
    • Business Women’s Breakfast Meeting – promoting a career plus children 2002
    • University Careers Day, student recruitment at Secondary Schools, Expos for Career Choices and Education, and other events including Be A Uni Student for the Day
    • Convenor Medical Research Week, WA: Gala Dinners, Medical Research Symposia, Hospital Health Expositions, Careers Information Evenings, Stakeholders Meetings 1999-2001
       Conference proceedings Note name change Lawson= James= Berry
    • Chuang L-W, Huang W-H, Hung J-H, James C, Chen DS, Chen P-J, Huang M-H. (2010). Age-dependent regulation of anti-HBV immunity by type I interferon signaling pathway. International Congress of Immunology, Kobe, Japan.
    • James CM, Fenwick SG, Ellis T. (2008). A novel biomarker of avian influenza vaccination in poultry for use in H5N1 surveillance. Australasian Society for Immunology, Perth Immunology Group Meeting, Perth, Western Australia, Australia.
    • Gerlach N, Gibbert K, Nair S, James, C, Dittmer U. (2008). Induction of IFN alpha subtypes by TLR agonists and their potency for antiretroviral therapy.  Immunology Congress, Vienna, Austria.
    • James CM, Mansfield J, Middleton D, Fenwick S, Ellis T. (2008). Tetanus toxoid as a positive marker for avian influenza vaccination in poultry. Avian Immunology Research Group, Gold Coast, Queensland, Australia.
    • Berry CM, Stumbles P, Gibbs G, Mansfield J, Lisciandro J, Gerlach N, Dittmer U. (2008). Anti-influenza viral effects of type I interferon subtypes in vivo and differential stimulation of dendritic cell activation, antigen processing and presentation to T cells. Innate Sculpting of Adaptive Immunity, Hamilton Island, Queensland, Australia.
    • James CM, Foong YY, Mansfield JP, Fenwick SG, Ellis TM. (2007). Use of tetanus toxoid as a DIVA (differentiating infected from vaccinated animals) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Options for the Control of Avian Influenza, Toronto, Canada.
    • James CM, Foong YY, Mansfield JP, Fenwick SG, Ellis TM. (2007). Sero-surveillance of avian influenza virus vaccination in ducks using tetanus toxoid as a DIVA strategy. Options for the Control of Avian Influenza, Toronto, Canada.
    • James CM, Foong YY, Mansfield JP, Fenwick SG, Ellis TM. (2007). Use of tetanus toxoid as a DIVA (differentiating infected from vaccinated animals) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Combined Biological Sciences 17th Annual Meeting, Perth, Australia.
    • Foong YY, James CM, Mansfield JP, Fenwick SG, Ellis TM. (2007). Sero-surveillance of avian influenza virus vaccination in ducks using tetanus toxoid as a DIVA strategy. Combined Biological Sciences 17th Annual Meeting, Perth, Australia.
    • Rezazadeh Vind A, Foong YY, Mansfield JP, James CM, (2007). A novel DIVA (differentiating infected from vaccinated) strategy with influenza vaccination in ducks. Australian Society for Medical Research, Annual Medical Research Symposium, Perth, Australia.
    • James CM, Lisciandro J, Gerlach, N, Dittmer, U, Stumbles, P. (2007). Interferon-alpha subtypes differentially enhance dendritic cell biology. International Society for Interferon and Cytokine Research Annual Meeting, Oxford, England.
    • Gerlach, N, Alter, C, James, CM, and Dittmer, U. (2007). Anti-retroviral effects of type I interferon subtypes in vivo. International Society for Interferon and Cytokine Research Annual Meeting, Oxford University, England.
    • Fenwick, SG, James CM, Foong, YY, Mansfield, JP, Ellis TM. (2007). The use of tetanus toxoid for sero-surveillance of avian influenza virus vaccination in poultry. Conference on Emerging Zoonoses, Limassol, Cyprus.
    • James CM, Foong YY, Mansfield JP, Fenwick SG, Ellis TM. (2007). Evaluation of tetanus toxoid as a positive marker for avian influenza vaccination of poultry- efficacy in vaccine/H5N1 challenge study. Vaccine Congress, Amsterdam, The Netherlands.
    • James, CM, Abdad, MY, Mansfield, JP, Jacobsen, HK, and Bartlett, EJ. (2006). Interferon-alpha transgene treatment enhances protection of DNA vaccinated mice from influenza virus challenge. Advances in Influenza Virus Research: From Birds to Bench to Bedside. Keystone Symposium, Steamboat Springs, Colorado, USA.
    • James, CM, Abdad, MY, Mansfield, JP, Jacobsen, HK, Stumbles, PS, and Bartlett, EJ. (2006). IFN-alpha transgene treatment enhances protection of DNA vaccinated mice from influenza virus challenge. Australasian Vaccines and Immunotherapeutics Development Meeting, Bio 21 Institute, Melbourne, Australia.
    • James, CM. (2006). Differential efficacies of the type I interferons in immunomodulating disease. Graduiertenkolleg 1045, Immunomodulation and Signal Transduction in Infectious Diseases, Emden, Germany.
    • James CM, Lisciandro JG, Stumbles PA, Abdad MY, Mansfield JP. (2006). Investigation of interferon stimulation of dendritic cells for influenza virus vaccine development. International Society for Interferon and Cytokine Research meeting, Vienna, Austria.
    • Shan S, Edwards J, Ellis T, Fenwick S, James CM. (2006). Development and immunological evaluation of a novel DNA vaccine against avian influenza. National Meeting, CRC-Australian Biosecurity, Cairns, Australia.
    • James, CM, Abdad, MY, Mansfield, JP, Jacobsen, HK, and Bartlett, EJ. (2005). Interferon-alpha 6 adjuvant therapy for improving efficacy of influenza A DNA vaccines. Australasian Society for Immunology Annual Meeting, Melbourne, Vic., Australia.
    • Bozanich, EM, Collins, R, Thamrin, C, James, C, Turner, DJ, Sly, PD. (2004). Acute physiological and cellular response to influenza A infection in mice. Thoracic Society of Australia and NZ, Sydney, Australia.
    • Carr, DJJ, Silverman, R, James, C, and Williams, BRG. (2004). The application of type I interferon transgenes to the cornea as a means to dampen HSV-1-induced pathology. XVI International Congress of Eye Research, Sydney, Australia.
    • Stumbles, P, von Garnier, C, Wikstrom, M, Smith, M, Thomas, J, Napoli, S, Holt, P, James, C. (2004). Kinetics and function of airway mucosal and peripheral lung dendritic cell subsets during primary influenza infection. 8th International Symposium on Dendritic Cells, Brugge, Belgium.
    • Carr, D, and James, C. (2003). Interferon-beta is superior to interferon-alpha species in hindering herpes simplex virus type 1 replication in primary trigeminal ganglion cell cultures. International Psychoneuroimmunology Society Meeting, Amelia Is., USA.
    • Carr, DJJ, and James, CM. (2003). A comparison of type I interferons in antagonizing ocular herpes simplex virus type 1 infection in mice: association with 2’,5’oligoadenylate synthetase expression. American Association of Immunologists Meeting, Denver, USA.
    • Cull, VS, Tilbrook, PA, Bartlett, EJ, Brekalo, NL, and James, CM. (2003). Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. International Society for Interferon and Cytokine Research, Cairns, Australia.
    • Bartlett, EJ, Lenzo, JC, Mansfield, JP, Sivamoorthy, S, Cull, VS, and James, CM. (2003). Murine cytomegalovirus-induced myocarditis: modulation of cardiac cytokine expression and cellular infiltration with interferon-alpha therapy. International Society for Interferon and Cytokine Research, Cairns, Australia.
    • Stumbles, PA, Smith, M, Tobagus, I, Thomas, JA, Bozanich, L, Turner, D, Sly, PD, James, CM, Holt, PG. (2003). Influenza infection and the post-natal development of mouse respiratory APC. Australasian Society for Immunology, Perth, Australia.
    • Carr, DJJ, Cull, VS and James, CM. (2002). Mouse cornea tranfected with plasmid containing interferon-beta transgene is superior to other type I interferon transgenes in antagonizing viral-mediated mortality. Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, USA.
    • Cull, V, Lenzo, J, Bartlett, E, and James, CM. (2002). Cytomegalovirus infection and autoimmune disease. 8th Australasian Autoimmunity Workshop, Melbourne, Vic.
    • Eade, J, Robertson, I, Lawson, M, Hinds, L, and James, CM. (2002). Naked DNA immunisation of the domestic cat with feline zona pellucia B and C genes. International Symposium on Nonsurgical Contraceptive Methods for Pet Population Control, GA, USA.
    • Cull, V, Broomfield, S, Bartlett, E, Brekalo, N, and James, CM. (2002). Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocardiis in gB DNA-vaccinated mice. International Joint Meeting Cytokines and Interferons, Torino, Italy.
    • Cull, V, Bartlett, E., and Lawson, CM. (2001). The role of type I interferons in induction of adaptive immunity in cytomegalovirus infection. International Congress of Immunology, Stockholm, Sweden.
    • Lawson, CM. (2001). Cytomegalovirus-myocarditis: the heart of the matter. Australian Society for Microbiology Annual Scientific Meeting, Perth, WA.
    • Carr, DJJ, Harle, P, AgBaga, M-P, Cull V, and Lawson, CM. (2001). A comparison of the anti-viral efficiacy of murine type I IFN transgene against herpes simplex type 1. International Society for Interferon and Cytokine Research, Maui, Hawaii.
    • Lawson, CM, Cull, VS, and Bartlett, E. (2001). The role of type I interferons in induction of adaptive immunity in cytomegalovirus infection. Australian Society for Medical Research Annual Scientific Meeting, Gold Coast, Qld.
    • Lawson, CM. (2000). Immunocontraception for feral cats. The Australian Veterinary Association Annual Meeting, Perth, W.A.
    • Harle, P, Lawson, CM, Cull, V, Carr, DJ. (2000). Transfections of L929 cells with plasmids encoding for type I interferon confers resistance to herpes simplex virus type 2. International Society of Neurovirology, San Francisco, USA.
    • Cull, V, Tilbrook, PA, Beilharz, MW, Klinken, SP, and Lawson, CM. (2000). Efficacy of type I interferons in J2E cell proliferation, differentiation and development of erythroleukemia. Third Joint Meeting of the International Cytokine Society and the International Society for Interferon and Cytokine Research, Amsterdam, Netherlands.
    • Bartlett, E, Cull, V, Beilharz, MW, and Lawson, CM. (2000). Immunisation of mice with DNA encoding type I IFN subtypes protects against cytomegalovirus infection and disease. Third Joint Meeting of the International Cytokine Society and the International Society for Interferon and Cytokine Research, Amsterdam, Netherlands.
    • Lenzo, JC, Shellam, GR, and Lawson, CM. (2000). The effect of ganciclovir and cidofovir on cytomegalovirus-induced myocarditis. International Herpesvirus Workshop, Portland, USA.
    • Harle, P, Cull, V, Lawson, C, and Carr, D. (2000). Transfections of L929 cells with plasmid cassettes encoding type I interferon subtypes confers resistance to herpes simplex virus type 2. International Society for Neurovirology Meeting, SF, USA.
    • Lenzo, JC, Shellam, GR, and Lawson, CM. (2000). The role of TNFa in murine cytomegalovirus-induced myocarditis. 30th Annual Conference of The Australasian Society for Immunology, Sydney, NSW.
    • Bartlett, E, Cull, V, Beilharz, MW, and Lawson, CM. (2000). Type I interferon DNA vaccines protect against cytomegalovirus infection. 39th National Scientific Conference, Australian Society for Medical Research, Melbourne, Vic.
    • Fairweather, D, Kaya, Z, Shellam, GR, Lawson, CM, and Rose, NR. (2000). From infection to autoimmunity. World Health Organisation Meeting on Autoimmunity, Geneva, Switzerland.
    • Broomfield, S, Cull,V, and Lawson, CM. (2000). Vaccination of mice against cytomegalovirus using DNA encoding viral envelope glycoprotein B and interferon-beta. Combined Biological Sciences Meeting, Perth, WA.
    • Krishnamurthy, P, Lawson, CM, and Allan, JE. (2000). Effects of virus vaccination on the development of cytomegalovirus-induced myocarditis. Combined Biological Sciences Meeting, Perth, WA
    • Bartlett, E, Cull, V, Beilharz, MW and Lawson, CM. (2000). Type I interferon DNA vaccines protect against cytomegalovirus. Combined Biological Sciences Meeting, Perth, WA
    • Bosio E, Lawson, CM, and Beilharz, MW. (1999). Routes of low dose IFN administration and heart disease. Congress of the International Society for Interferon and Cytokine Research, Paris, France.
    • Lenzo, JC, Shellam, GR, and Lawson, CM. (1999). Therapeutic effects of ganciclovir and foscarnet on cytomegalovirus-induced myocarditis. International Congress of Virology, Sydney, NSW.
    • Lenzo, JC, Fairweather, D, Shellam, GR, and Lawson, CM. (1999). Immunomodulation of cytomegalovirus-induced myocarditis in mice resistant to cardiovascular disease. The Australasian Society for Immunology Meeting, Dunedin, New Zealand.
    • Cull, V, Bartlett, E, Beilharz, MW, and Lawson, CM. (1999). Immunization of mice with DNA encoding various type I interferons protects against cytomegalovirus infection and disease. The Australasian Society for Immunology Meeting, Dunedin, New Zealand.
    • Bosio, E, Lawson, CM, and Beilharz, MW. (1999). Routes of low dose IFN administration and heart disease. Combined Biological Sciences Meeting, Perth, WA.
    • Lenzo, JC, Shellam, GR, and Lawson, CM. (1999). Anti-viral therapies for cytomegalovirus-induced myocarditis. Combined Biological Sciences Meeting, Perth, WA.

    Conference proceedings prior to Murdoch

    • Lawson, CM, and Beilharz, MW. (1998). Low-dose oral interferon inhibits virally induced myocarditis. International Society for Interferon and Cytokine Research Meeting, Jerusalem, Israel.
    • Beilharz, MW, and Lawson, CM. (1998). Cytokine gene therapy: intramuscular injection of interferon expression constructs. International Society for Interferon and Cytokine Research Meeting, Jerusalem, Israel.
    • Lawson, CM, and Beilharz, MW. (1998). Cytokine gene therapy for viral myocarditis: naked DNA encoding interferon-alpha 1. The Australasian Society for Immunology Meeting, Melbourne, Victoria.
    • Beilharz, MW, and Lawson, CM. (1998). Suppression of viral myocarditis by intramuscular immunization with naked DNA expressing the interferon alpha 1 transgene. Combined Biological Sciences Meeting, Perth, WA.
    • Lawson, CM, and Beilharz, MW. (1998). Low-dose oral interferon inhibits virally induced myocarditis. Combined Biological Sciences Meeting, Perth,WA.
    • Lenzo, J, Fairweather, D, Singh, B, Shellam, GR, and Lawson, CM. (1998). LPS exacerbates MCMV-induced myocarditis in both susceptible and resistance mouse strains. Combined Biological Sciences Meeting, Perth, WA.
    • Bartlett, E, Beilharz, MW, and Lawson, CM. (1998). Differential transcriptional activation of the interferon-stimulated genes by the individual type I interferon subtypes. Combined Biological Sciences Meeting, Perth, WA.
    • Fairweather, D, Shellam, GR, and Lawson, CM. (1997). Viral and immune mechanisms associated with cytomegalovirus-induced myocarditis. Keystone Symposium, Colorado, USA.
    • Epstein, S, Lo, C-Y, Misplon, J, Lawson, CM, Hendrickson, B, Max, E, and Subbarao, K. (1997). Roles of T cells and J chain-bearing antibodies in protection against heterosubtypic influenza infection in mice. Keystone Symposium, New Mexico, USA.
    • Beilharz, MW, McDonald, W, Watson, M, Heng, J, McGeachie, J, and Lawson, CM. (1997). Low dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo. International Society for Interferon and Cytokine Research Meeting, San Diego, USA.
    • Yeow, W-S, Lawson, CM, and Beilharz, MW. (1997). Antiviral activities of individual murine interferon alpha subtypes in vivo. International Society for Interferon and Cytokine Research Meeting, San Diego, USA.
    • Lawson, CM, Yeow, W-S, and Beilharz, MW. (1997). Differences in antiviral activities of murine interferon alpha subtypes in vivo. The Australasian Society for Immunology Meeting, Perth, WA.
    • Fairweather, D, Shellam,GR, and Lawson, CM. (1997). Persistence of cytomegalovirus in the heart does not correlate with chronic myocarditis. The Australasian Society for Immunology Meeting, Perth, WA.
    • Lawson, CM. (1997). Cytomegalovirus: myocarditis and therapeutic strategies. The Australasian Society for Immunology Meeting, Perth, WA. Invited symposium.
    • Bosio, E, Lawson, CM, Watson, MW, and Beilharz, MW. (1997). Low dose oral type I interferons reduce early virus replication of murine cytomegalovirus. Combined Biological Sciences Meeting, Perth, WA.
    • Yeow, W-S, Beilharz, MW, and Lawson, CM. (1997). In vivo differences in the antiviral activities of individual murine interferon alpha subtypes. Combined Biological Sciences Meeting, Perth, WA.
    • Fairweather, D, Shellam, GR, and Lawson, CM. (1997). Persistence of cytomegalovirus in the heart does not correlate with chronic myocarditis. Combined Biological Sciences Meeting, Perth, WA.
    • Lawson, CM,Yeow, W-S , Lee,CL, and Beilharz, MW. (1996). Murine type I interferon transgene expression in vivo following intramuscular inoculation of naked DNA. Growth Factor and Signal Transduction Conference, Ames, Iowa, USA.
    • Fairweather, D, Shellam, GR, and Lawson, CM. (1996). MCMV-induced myocarditis:  NK cells protect against and CD4/8 T cells induce disease. The Australasian Society for Immunology, Adelaide, SA.
    • Yeow, W-S, Lawson, CM, and Beilharz, MW. (1996). Over expression of an interferon alpha gene by intramuscular injection of naked DNA. The Australian Society for Medical Research, Gold Coast, Qld.
    • Yeow, W-S, Lawson, CM, Lee, CL, and Beilharz, MW. (1996). Naked DNA transgene expression for murine type I interferons. Combined Biological Sciences Meeting, Perth, WA.
    • Fairweather, D, Shellam, GR, and Lawson, CM. (1996). The role of cytomegalovirus in inflammatory heart disease. Combined Biological Sciences Meeting, Perth, WA.
    • Garlepp, M, Tabbarias, H, Blechynden, L, Lawson, CM, Van Bockxmeer, F, and Mastaglia, F. (1995). Genetic factors in inclusion body myositis. Inclusion Body Myositis Meeting, Marseille, France.
    • Fairweather, D, Chapman, AJ, Booth, TWM, Lawson, CM, Lathbury, LJ, Scalzo, AA, Garlepp, MJ, and Shellam, GR. (1995). Mechanisms of murine cytomegalovirus-induced myocarditis. Australian Society for Microbiology, Sydney, NSW.
    • Lawson, CM, Blechynden, LM, Garlepp, MJ, Sherman, J, and Raben, N. (1995). Naked DNA inoculation of the gene for histidyl-tRNA synthetase: A possible model for autoimmune polymyositis. The Australasian Society for Immunology, Gold Coast, Qld.
    • Blechynden, LM, Lawson, CM, and Garlepp, MJ. (1995). Cloning and sequence characterization of the murine gene for histidyl-tRNA synthetase and its application in a murine model for autoimmune polymyositis. The Australasian Society for Immunology, Gold Coast, Qld.
    • Blechynden, L, Garlepp, M, and Lawson, CM. (1995). Induction of an immune response to plasmid-encoded autoantigen, histidyl-tRNA synthetase by direct gene transfer. Combined Biological Sciences Meeting, Perth, WA.
    • Subbarao, EK, Lawson, CM, and Murphy, BR. (1994). Rescue of mutant derivatives of an influenza A virus PB2 gene confirms that the mutations specify temperature sensitivity. American Society for Virology 13th Annual Meeting, Madison, USA.
    • Epstein, SL, Lo, C-Y, Misplon, JA, Murphy, BR, Lawson, CM, and Subbarao, EK. (1994). Mediators of heterosubtypic immunity to influenza A virus infection of mice. Modern Approaches to New Vaccines including the Prevention of AIDS, Cold Spring Harbor, New York, USA.
    • Lawson, CM, Subbarao, EK, and Murphy, BR. (1994). Influenza viruses with synthetic genes- a new approach to vaccines. Combined Biological Sciences Meeting, Perth, WA.
    • Lawson, CM, Epstein, SL, Misplon, J, Bennink, J, Yewdell, J, and Murphy, BR. (1993). Vaccinia-influenza recombinant viruses protect mice against influenza A virus infection. American Society for Virology 12th Annual Meeting, Davis, USA.
    • Lawson, CM, and Murphy, BR. (1992). Nucleotide sequence changes in live attenuated temperature-sensitive mutants of influenza A/Udorn/307/72 (H3N2) virus. American Society for Virology 11th Annual Meeting, Ithica, USA.
    • Epstein, SL, Misplon, JA, Lawson, CM, Subbarao, EK, and Murphy, BR. (1992). Vaccination with HA- and NA- vaccinia-influenza recombinants provide protective immunity to influenza A virus. Annual Research Festival, National Institutes of Health, MD, USA.
    • Lawson, CM, O’Donoghue, H, and Reed, WD. (1990). Autoantibodies to cardiac myosin in cytomegalovirus myocarditis. VIIIth International Congress of Virology, Berlin, Germany.
    • Lawson, CM, O’Donoghue, H and Reed, WD. (1989). Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis. Australian Society for Immunology Annual Scientific Meeting, Adelaide, SA.
    • Lawson, CM, O’Donoghue, H, and Reed, WD. (1989). Cytomegalovirus myocarditis-immunological aspects. Royal Australasian College of Physicians, Perth, WA.
    • Lawson, CM, O’Donoghue, HL and Reed, WD. (1988). Cytomegalovirus and myocarditis in the mouse. Joint Meeting of the Sektion Virologie der Deutschen Gesellschaft fur Hygiene und Mikrobiologie and the Virus Group of the Society for General Microbiology, Hamburg, West Germany.
    • Lawson, CM, O’Donoghue, H , and Reed, WD. (1988). The role of T cells in mouse cytomegalovirus myocarditis. Australian Society for Immunology Annual Scientific Meeting, Brisbane, Qld.
    • Lawson, CM, Grundy, JE and Shellam, GR. (1985). Mediators of genetically-determined resistance to murine cytomegalovirus infection. Australian Society for Microbiology Annual Scientific Meeting, Perth, WA.
    • Lawson, CM, Grundy, JE and Shellam, GR. (1984). Humoral responses to murine cytomegalovirus. Australian Society for Immunology Annual Scientific Meeting, Perth, WA.

    Professional and community service

    University Teaching service 
    2019 – present    Elected Member, Board of College Science, Health, Engineering and Education
    2017-2018          Chair, Institutional Biosafety
    2017-2018          Member Safety in Teaching &  Research Committee
    2012-2018          Member, Promotions & Probationary Review Committees
    2009                   Academic Review Committee, School of Biological Sciences & Biotechnology
    2008                   Academic Review Committee, School of Law
    2006-2008          Program Chair, Biomedical Science Program and Academic Advisor
    2006-2008          Chair, Curriculum & Education Quality Committee, Biomedical Science
    2006-2008          Member, Academic Council
    2003-6/2014-15 Chair, Marketing Committee, Division of Health Sciences
    2001-2002          Member, School of Veterinary Biology Committee
    2000-2002          Member, Division of Health Sciences Board
    1999-2002          Member, Board of Research and Development
    1999- present     Invited examiner of PhD, Masters and Honours theses
    University Research service
    Research Integrity Advisor, School of Veterinary and Life Sciences, Murdoch University
    Chair, Working Party, Safety and Security in Science, Murdoch University
    Member, Research Committee, Division of Veterinary & Biomedical Sciences, Murdoch University
    Member, Animal Users Committee, The University of Western Australia
    Community service
    As Convenor for Medical Research Week in WA, I coordinated events and led a team of volunteers to present gala dinners with the national Visiting Professor (ASMR medalist), medical research symposiums, public health expos, careers information sessions for secondary school students, workshops for commercialisation of research, and science in art open days.
    Chosen as a Real Life Hero for National Science Week.
    Promoted medical research and women in science through forums and media engagements, including print, radio and television.

    Doctoral and masters supervisions

    I have supervised the following students to completion:
    Castley, Alison (2016) Filling the gaps: Towards improved surveillance and monitoring of immunological status relevant to long term co-morbidities in HIV infection. PhD thesis, Murdoch University.
    Strautins, Kaija (2015) Investigating the role of Epstein-Barr virus in the pathogenesis of Multiple Sclerosis. PhD thesis, Murdoch University.
    Rinaldi, Catherine (2015) Prevention of influenza virus infection using ruminant polyclonal antibodies. PhD thesis, University of Western Australia.
    Proal, Amy (2012) Autoimmune disease re-examined in light of metagenomic concepts.PhD thesis, Murdoch University.
    Abdad, Mohammad (2011) An epidemiological and serological study of Rickettsia in Western Australia. PhD thesis, Murdoch University.
    Shan, Songhua (2010) Development and evaluation of DNA vaccines in chickens against a wild bird H6N2 avian influenza virus from Western Australia. PhD thesis, Murdoch University.
    Chua, Tze Hoong (2009) Studies on the diagnosis, epidemiology and control of highly pathogenic H5N1 avian influenza. PhD thesis, Murdoch University.
    Smuts, Celia (2009) Development of tools to improve the detection of Trypanosoma evansi in Australia. PhD thesis, Murdoch University.
    Eade, Jocye A. (2007) Investigating porcine and feline zona pellucida as immunocontraceptive antigens in the female domestic cat. PhD thesis, Murdoch University.
    Bartlett, Emmalene J. (2002) Efficacy and immunological mechanisms of type 1 interferon gene therapy in murine cytomegalovirus. PhD thesis, Murdoch University.
    Lenzo, Jason (2002) Immunomodulation of cardiovascular disease: murine studies of cytomegalovirus myocarditis. PhD thesis, The University of Western Australia.
    Bosio, Erika (2001) Effects of low dose oral administration of type I interferons. PhD thesis, The University of Western Australia.
    Fairweather, DeLisa (2000) Viral and immunological pathogenic mechanisms in cytomegalovirus-induced  myocarditis. PhD thesis, The University of Western Australia.
    Yeow, Wen-Shuz (1999) The expression and antiviral properties of the individual type I interferon subtypes. PhD thesis, The University of Western Australia.
    Honours research students
    Back, Chelsea (2011) Induction of programmed cell death in mammalian cells by isolates of Ross River virus. Honours thesis, Murdoch University.
    Pemberton, Dean (2009) Dendritic cell function and type I interferon subtype production following Ross River virus infection. Hons thesis, Murdoch University.
    Rezazadeh Vind, Azita (2007) Avian influenza vaccination in ducks using tetanus toxoid as a positive marker for vaccination. Hons thesis, Murdoch University.
    Lisciandro, Joanne (2006) Investigation of interferon stimulation of dendritic cells for influenza virus vaccine development. Hons thesis, Murdoch University.
    Nelson, Jan (2006) Development of mucosal immunity to Streptococcus pneumoniae and haemophilus influenzae in children and the relationship to otitis media and nasopharyngeal carriage. Hons thesis, Murdoch University.
    Ward, Vanessa (2005) Immune responses of preterm infants, term infants and adults to group B streptococcus and related stimuli. Hons thesis, Murdoch University.
    Abdad, M. Yazid (2004) Type I IFN (-alpha 6) enhancement of haemaglutinin DNA vaccine for influenza virus. Hons thesis, Murdoch University.
    Archer, Brendon (2003) Protective immunity elicited by IFN/gB CMV DNA vaccine. Hons thesis, Murdoch University.
    Irwin, Samantha (2003) Immune responses of maternal and cord blood lymphocytes to neonatal pathogens. Hons thesis, Murdoch University.
    Mowe, Eva (2002) Characterisation of interferon and viral gB DNA vaccine mediated protection against cytomegalovirus. Hons thesis, Murdoch University.
    Sivamoorthy, Soruba (2002) The role of IFN-alpha 6 DNA therapy in immunomodulation of cytomegalovirus-induced myocarditis. Hons thesis, Murdoch University.
    Broomfield, Steve (2000) Vaccination of mice against cytomegalovirus using DNA encoding viral envelope glycoprotein B and interferon-beta. Hons thesis, Murdoch University.
    Krishnamurthy, Priya (2000) Effects of virus vaccination on the development of cytomegalovirus-induced myocarditis. Hons thesis, Murdoch University.
    Bartlett, Emmalene (1998) Analysis of the role of individual interferon subtypes in the transcription activation of the interferon stimulated genes. Hons thesis, The University of Western Australia.
    Bosio, Erika (1997) The mechanism of action of low dose oral type I interferon. Hons thesis, The University of Western Australia.
    McDonald, Wade (1996) Are current modes of interferon administration appropriate? Hons thesis, The University of Western Australia.

    Publications

    Chapters

    • Berry, C., Bartlett, E., Mansfield, J., Cull, V., (2005),Interferon subtype gene therapy for regulating cytomegalovirus disease,In: Methods in Molecular Medicine, Humana Press, pages 207 to 219.

    Journals

    • Berry, C., (2017), A Technique for Inspiring Scientific Inquiry Using a Creative Scenario, The American Biology Teacher, 79, 8, pages 671 - 677.
    • Berry, C., (2017), Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies?, Human Vaccines and Immunotherapeutics, , Aug 30, pages -.
    • Berry, C., (2016), Understanding Interferon Subtype Therapy for Viral Infections: Harnessing the Power of the Innate Immune System., Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2016.08.001, , pages -.
    • Castley, A., Williams, L., James, I., Guelfi, G., Berry, C., Nolan, D., (2016), Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors, PLoS One, 11, 6, pages -.
    • Berry, C., (2015), Towards a universal influenza virus vaccine eliciting broadly neutralising haemagglutinin antibodies, Journal of Vaccines and Vaccination, 6, 5, pages 1000303 -.
    • Cha, L., Berry, C., Nolan, D., Castley, A., Fernandez, S., French, M., (2014), Interferon-alpha, immune activation and immune dysfunction in treated HIV infection, Clinical and Translational Immunology, 3, 0, pages 0 - 0.
    • Strickland, D., Fear, V., Shenton, S., Wikstrom, M., Zosky, G., Larcombe, A., Holt, P., Berry, C., von Garnier, C., Stumbles, P., (2014), Persistent and Compartmentalised Disruption of Dendritic Cell Subpopulations in the Lung following Influenza A Virus Infection, PLoS One, 9, 11, pages -.
    • Castley, A., Berry, C., French, M., Fernandez, S., Krueger, R., Nolan, D., (2014), Elevated Plasma Soluble CD14 and Skewed CD16+Monocyte Distribution Persist despite Normalisation of Soluble CD163 and CXCL10 by Effective HIV Therapy: A Changing Paradigm for Routine HIV Laboratory Monitoring?, PLoS One, 9, 12, pages -.
    • Berry, C., Penhale, W., Sangster, M., (2014), Passive Broad-Spectrum Influenza Immunoprophylaxis, Influenza Research and Treatment, 2014, Article ID 267594, pages -.
    • Rinaldi, C., Penhale, W., Stumbles, P., Tay, G., Berry, C., (2014), Modulation of Innate Immune Responses by Influenza-Specific Ovine Polyclonal Antibodies Used for Prophylaxis, PLoS One, 9, 2, pages 0 - 0.
    • Berry, C., (2013), Vaccine Control of Avian Influenza H5N1 in Poultry: Need for a Positive Marker, Journal of Vaccines and Vaccination, 4, 168, pages 1 - 4.
    • Poinern, G., Ali, N., Berry, C., Singh, P., Fawcett, D., Berchmans, S., (2012), Biocompatibility of Synthesised Nano-Porous Anodic Aluminium Oxide Membranes for Use as a Cell Culture Substrate for Madin-Darby Canine Kidneys Cells: A Preliminary Study, Journal of Tissue Science & Engineering, 3, 3, pages 1 - 7.
    • Berry, C., Hertzog, P., Mangan, N., (2012), Interferons as biomarkers and effectors: lessons learned from animal models, Biomarkers in Medicine, 6, 2, pages 159 - 176.
    • Le, X., Poinern, G., Ali, N., Berry, C., Fawcett, D., (2012), Engineering a Biocompatible Scaffold withEither Micrometre or Nanometre Scale Surface Topography forPromoting Protein Adsorption and Cellular Response, International Journal of Biomaterials, 201, Article ID 782549, pages 1 - 16.
    • Bayer, W., Lietz, R., Ontikatze, T., Johrden, L., Tenbusch, M., Nabi, G., Schimmer, S., Groitl, P., Wolf, H., Berry, C., Überla, K., Dittmer, U., Wildner, O., (2011), Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes, Retrovirology, 8, 1, pages 1 - 15.
    • Berry, C., Mansfield, J., Fenwick, S., Ellis, T., (2010), Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine, Veterinary Record, 167, , pages 695 - 699.
    • Chua, T., Leung, C., Fang, H., Chow, C., Ma, S., Sia, S., Ng, I., Fenwick, S., Berry, C., Chua, S., Chew, S., Kwang, J., Peiris, J., Ellis, T., (2010), Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian InfluenzaMarker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus, Influenza Research and Treatment, 2010, 1, pages 1 - 10.
    • Gerlach, N., Gibbert, K., Alter, C., Nair, S., Zelinskyy, G., Berry, C., Dittmer, U., (2009), Anti-retroviral effects of type I IFN subtypes in vivo, European Journal of Immunology, 39, 1, pages 136 - 146.
    • Eade, J., Robertson, I., Berry, C., (2009), Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats, Reproduction, 137, 6, pages 913 - 922.
    • Berry, C., Foong, Y., Mansfield, J., Rezazedeh Vind, A., Fenwick, S., Ellis, T., (2008), Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance., Vaccine, 26, , pages 5345 - 5351.
    • Berry, C., Foong, Y., Mansfield, J., Fenwick, S., Ellis, T., (2007), Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry., Vaccine, 25, 31, pages 5892 - 5901.
    • Berry, C., Abdad, M., Mansfield, J., Jacobsen, H., Rezazedeh Vind, A., Stumbles, P., Bartlett, E., (2007), Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein, Vaccine, 25, 10, pages 1856 - 1867.
    • Austin, B., Berry, C., Harle, P., Carr, D., (2006), Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality, Biological Procedures Online, 8, , pages 55 - 62.
    • Austin, B., Berry, C., Silverman, R., Carr, D., (2005), Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN- during acute ocular herpes simplex virus type 1 infection, Journal of Immunology, 175, 2, pages 1100 - 1106.
    • Bartlett, E., Lenzo, J., Sivamoorthy, S., Mansfield, J., Cull, V., Berry, C., (2004), Type I IFN-b gene therapy suppresses cardiac CD8+T cell infiltration during autoimmune myocarditis, Immunology and Cell Biology, 82, 2, pages 119 - 126.
    • Cull, V., Tilbrook, P., Bartlett, E., Brekalo, N., Berry, C., (2003), Type I interferon differential therapy for erythroleukemia: Specificity of STAT activation, Blood, 101, 7, pages 2727 - 2735.
    • Carr, D., Al-Khatib, K., Berry, C., Silverman, R., (2003), Interferon-beta suppresses herpes simplex virus type I-replication in trigemminal ganglion cells through a RNase L-dependent pathway., Journal of Neuroimmunology, 141, , pages 40 - 46.
    • Lenzo, J., Mansfield, J., Sivamoorthy, S., Cull, V., Berry, C., (2003), Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy., Cellular Immunology, 223, , pages 77 - 86.
    • Bartlett, E., Cull, V., Mowe, E., Mansfield, J., Berry, C., (2003), Optimisation of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection., Biological Procedures Online, 5, , pages 43 - 52.
    • Cull, V., Broomfield, S., Bartlett, E., Brekalo, N., Berry, C., (2002), Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice, Gene Therapy (Basingstoke), 9, , pages 1369 - 1378.
    • Cull, V., Bartlett, E., Berry, C., (2002), Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis, Immunology: the journal of cells, molecules, system and technologies, 106, , pages 428 - 437.
    • Harle, P., Cull, V., Agbaga, M., Silverman, R., Williams, B., Berry, C., Carr, D., (2002), Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication, Journal of Virology, 76, 13, pages 6558 - 6567.
    • Harle, P., Cull, V., Guo, L., Papin, J., Berry, C., Carr, D., (2002), Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection, Antiviral Research, 56, , pages 39 - 49.
    • Lenzo, J., Fairweather, D., Cull, V., Shellam, G., Berry, C., (2002), Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence, Journal of molecular and cellular cardiology, 34, , pages 1 - 12.
    • Bartlett, E., Cull, V., Brekalo, N., Lenzo, J., Berry, C., (2002), Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection, Immunology and Cell Biology, 80, , pages 425 - 435.
    • Lenzo, J., Fairweather, D., Shellam, G., Berry, C., (2001), Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with Lipopolysaccharide and tumor Necrosis Factor, Cellular Immunology, 213, , pages 52 - 61.
    • Lenzo, J., Berry, C., (2001), Cytomegalovirus-induced myocarditis - an animal model for understanding pathogenesis and therapy., International Antiviral News, 9, , pages 166 - 169.
    • Fairweather, D., Kaya, Z., Shellam, G., Berry, C., Rose, N., (2001), From infection to autoimmunity, Journal of Autoimmunity, 16, , pages 175 - 186.
    • Lenzo, J., Shellam, G., Berry, C., (2001), Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice, Antimicrobial Agents and Chemotherapy (Print), 45, 5, pages 1444 - 1449.
    • Berry, C., (2000), Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis, Cellular and Molecular Life Sciences, 57, , pages 552 - 560.
    Patents
    • Patent (Australia) (Ellis, T, James, C, Fenwick, S) PCT/ U2006/001682: WO2007/053899,Differentiating Therapeutic Composition, International filing.
    • Patent (USA) (Murphy, BR, Subbarao, K, Lawson, CM, Chanock, R) continuation-in-partto serial no. 07/527,737 for the technology of gene rescue of the polymerase and matrix genes of human influenza viruses in the production of new influenza virus vaccines.
    Key publications prior to Murdoch
    Chapters
    • Epstein, SL, Lo, C-Y, Misplon, JA, Murphy, BR, Lawson, CM, and Subbarao, EK. (1995).Mediators of heterosubtypic immunity to influenza A virus infection in mice. RM Chanock, F Brown, HS Ginsberg, E. Norling (eds.). InVaccines 95, Molecular Approaches to the Control of Infectious Diseases, Cold Spring Harbor Laboratories, Cold Spring Harbor, NY. pp. 393-398.
    • Garlepp, MJ, Blechynden, L, Tabarias, H, Lawson, CM, Van Bockxmeer, F, and Mastaglia, FL. (1998). Genetic factors in sporadic inclusion-body myositis. Askanas V, Serratrice G & Engel, WK (eds). In Inclusion-Body Myositis and Myopathies, Cambridge University Press, pp.177-188.
    Journals
    • Lawson, CM, and Beilharz, MW. (1999). Low dose oral use of interferon inhibits virally induced myocarditis. J. Interferon Cytokine Res., 19: 863-867.
    • Bosio, E, Beilharz, MW, Watson, M, and Lawson, CM. (1999). Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. J. Interferon Cytokine Res., 19: 869-876.
    • Fairweather, D, Lawson, CM, Chapman, AJ, Brown, CMS, Booth, TWM, Papadimitriou, JM, and Shellam, GR. (1998). Wild isolates of murine cytomegalovirus induce myocarditis and antibodies which cross-react with myosin. Immunol., 94: 263-270.
    • Yeow, W-S, Lawson, CM, and Beilharz, MW. (1998) Antiviral activities of the individual murine interferon alpha subtypes in vivo: Naked DNA expression of interferon transgenes reduces murine cytomegalovirus replication intramuscularly. J. Immunol., 160: 2932-2939.
    • Beilharz, MW, McDonald, W, Watson, M, Heng, J, McGeachie, J, and Lawson, CM. (1997). Low dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo. J. Interferon Cytokine Res., 17: 625-630.
    • Lawson, CM, Yeow, W-S, Lee, CL, and Beilharz, MW. (1997). In vivo expression of an interferon alpha gene by intramuscular injection of naked DNA. J. Interferon Cytokine Res.,17: 255- 261.
    • Epstein, SL, Lo, C-Y, Misplon, JA, Lawson, CM, Hendrickson, B, Max, EE, and Subbarao, EK. (1997). Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in immunocompetent, T cell-depleted, b2-microglobulin-deficient, and J chain-deficient mice. J. Immunol., 158:1 222-1230.
    • Blechynden, LM, Lawson, MA, Tabarias, H, Garlepp, MJ, Sherman, J, Raben, N, and Lawson, CM. (1997). Myositis induced by naked DNA immunization with the gene for histidyl-tRNA synthetase. Human Gene Therapy, 8: 1469-1480.
    • Blechynden, LM, Lawson, CM, and Garlepp, MJ. (1996). Sequence and polymorphism analysis of the murine gene for histidyl-tRNA synthetase. Gene, 178: 151-156.
    • Subbarao, EK, Park, EJ, Lawson, CM, Chen, AY, and Murphy, BR. (1995). Sequential addition of temperature sensitive missense mutations to the PB2 gene of influenza A transfectant viruses leads to increasing levels of temperature sensitivity and attenuation and permits the rational design of a genetically engineered influenza A virus vaccine. J. Virol., 69: 5969-5977.
    • Lawson, CM, Bennink, JR, Restifo, NP, Yewdell, JW, and Murphy, BR. (1994). Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J. Virol., 68: 3505-3511.
    • Epstein, SL, Misplon, JA, Lawson, CM, Subbarao, EK, Connors, M, and Murphy, BR. (1993). ß2-microglobulin-deficient can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J. Immunol., 150: 5484-5493.
    • Lawson, CM, Subbarao, EK, and Murphy, BR. (1992). Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus. Virol. 191: 506-510.
    • Lawson, CM, O’Donoghue, HL, and Reed, WD. (1992). Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin. A model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunol., 75: 513-519.
    • Lawson, CM, O’Donoghue, HL, Farrell, HE, Shellam, GR, and Reed, WD. (1991). Murine anti-cytomegalovirus monoclonal antibodies with autoreactivity. Immunol., 72: 427-433.
    • Lawson, CM, O’Donoghue, H, Bartholomaeus, WN, and Reed, WD. (1990). Genetic control of cytomegalovirus induced myocarditis. Immunol., 69:20-26.
    • O’Donoghue, HL, Lawson, CM, and Reed, WD. (1990). Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis. Immunol., 71: 20-28.
    • Lawson, CM, Hodgkin, P, and Shellam, GR. (1990). The effect of cyclosporin A on major histocompatibility-linked resistance to murine cytomegalovirus. J. Gen Virol., 70: 1253-1259.
    • Lawson, CM, O’Donoghue, H, and Reed, WD. (1989). The role of T cells in mouse cytomegalovirus myocarditis. Immunol., 67: 132-134.
    • Bartholomaeus, WN, O’Donoghue, H, Foti, D, Lawson, CM, Shellam, GR, and Reed, WD. (1988). Multiple autoantibodies following cytomegalovirus infection: Virus distribution and specificity of autoantibodies. Immunol., 64: 397-405.
    • Lawson, CM, Grundy, JE, and Shellam, GR. (1988). Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J. Gen. Virol., 69: 1987-1998.
    • Lawson, CM, Grundy, JE, and Shellam, GR. (1987). Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J. Gen. Virol., 68: 2379-2388.